[Developments in the treatment of complications of neoplastic diseases].
D000728:Androgens / Q000494:pharmacology / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects; D001792:Blood Platelets; D001803:Blood Transfusion; D001854:Bone Marrow Cells; D001855:Bone Marrow Diseases / Q000209:etiology; D016026:Bone Marrow Transplantation; D006410:Hematopoiesis / Q000187:drug effects; D006801:Humans; D007239:Infections / Q000188:drug therapy / Q000209:etiology; D007676:Kidney Failure, Chronic / Q000209:etiology; D009369:Neoplasms / Q000150:complications* / Q000188:drug therapy / Q000601:surgery; D011008:Pneumococcal Infections / Q000188:drug therapy; D011183:Postoperative Complications / Q000188:drug therapy; D013290:Streptococcal Infections / Q000188:drug therapy; D014184:Transplantation, Homologous
D000728:Androgens; D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents